on December 4, 2006
Published online before print December 4, 2006, doi: 10.1161/CIRCULATIONAHA.106.611707
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on January 1, 2006
From the Department of Medicine, Denver Health Medical Center (F.A.M., E.P.H.), and Department of Medicine, University of Colorado Health Sciences Center (F.A.M., E.P.H.), Denver, Colo; Colorado Foundation for Medical Care (F.A.M., E.P.H.) and Colorado Health Outcomes Program (F.A.M.), Aurora, Colo; Department of Medicine, Yale University School of Medicine, New Haven, Conn (J.M.F., Y.W., H.M.K.); Qualidigm, Middletown, Conn (J.M.F., H.M.K.); Department of Medicine, West Haven VA Medical Center, West Haven, Conn (J.M.F.); Department of Medicine, New York University School of Medicine, New York, NY (M.J.R.); Birmingham/Atlanta VA Geriatric Research, Education, and Clinical Center, Birmingham, Ala (R.M.A.); Center for Aging and Division of Gerontology and Geriatric Medicine, University of Alabama at Birmingham (R.M.A.); Alabama Quality Assurance Foundation (R.M.A.), Birmingham, Ala; MetaStar, Madison, Wisc (J.G.); University of Iowa Carver College of Medicine, Iowa City (R.T.W.); Iowa Foundation for Medical Care, West Des Moines (R.T.W.); the Department of Epidemiology and Public Health, Yale School of Medicine, New Haven, Conn (H.M.K.); and Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Conn (H.M.K.). * To whom correspondence should be addressed. E-mail: fred.masoudi{at}uchsc.edu.
Background--Because of the health impact of acute myocardial infarction (AMI), substantial resources have been dedicated to improving AMI care and outcomes. Long-term trends in the clinical characteristics, quality of care, and outcomes for AMI over time from the health system perspective in geographically diverse populations are not well known. Methods and Results--The present study included 20 550 Medicare patients aged Conclusions--The quality of care and adjusted 1-year mortality improved significantly for Medicare beneficiaries with AMI during 1992-2001. Nevertheless, fewer were ideal for guideline-based therapy, and absolute mortality remains high, suggesting the need for treatment strategies applicable to a broader range of older patients.
Revised on September 29, 2006
Accepted on October 10, 2006
Trends in Acute Myocardial Infarction in 4 US States Between 1992 and 2001. Clinical Characteristics, Quality of Care, and Outcomes
Frederick A. Masoudi MD, MSPH*,
65 years hospitalized in 4 US states (Alabama, Connecticut, Iowa, Wisconsin) with the confirmed primary discharge diagnosis of AMI in 4 periods: 1992-1993 (n=10 292), 1995 (n=5566), 1998-1999 (n=2413), and 2000-2001 (n=2279). With the use of standard quality indicator definitions, treatment of ideal candidates with aspirin and 
-blockers within 24 hours after presentation, -blockers, and angiotensin-converting enzyme inhibitors at discharge was assessed. Multivariable models were constructed to calculate adjusted 1-year mortality. The hospitalized Medicare population with AMI changed substantially during 1992-2001, with increasing age, more comorbidity, and fewer meeting ideal treatment criteria. Although treatment rates increased significantly for all medications, aspirin, -blockers, and angiotensin-converting enzyme inhibitors were not provided at discharge to 12.6%, 19.7%, and 25.2% of ideal candidates, respectively, in 2000-2001. Crude 1-year mortality increased (27.6%, 28.3%, 30.6%, and 31.0%; P=0.003 for trend, but adjusted mortality declined (compared with 1992-1993, relative risk in 1995=0.94 [95% CI, 0.88 to 1.01]; relative risk in 1998-1999=0.91 [95% CI, 0.85 to 0.98]; relative risk in 2000-2001=0.87 [95% CI, 0.81 to 0.94]).
Key words: aging • epidemiology • morbidity • mortality • myocardial infarction • patients
This article has been cited by other articles:
 |
|
 |
|
  V. Vaccarino, L. Parsons, E. D. Peterson, W. J. Rogers, C. I. Kiefe, and J. Canto Sex Differences in Mortality After Acute Myocardial Infarction: Changes From 1994 to 2006 Arch Intern Med, October 26, 2009; 169(19): 1767 - 1774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Krumholz, Y. Wang, J. Chen, E. E. Drye, J. A. Spertus, J. S. Ross, J. P. Curtis, B. K. Nallamothu, J. H. Lichtman, E. P. Havranek, et al. Reduction in Acute Myocardial Infarction Mortality in the United States: Risk-Standardized Mortality Rates From 1995-2006 JAMA, August 19, 2009; 302(7): 767 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L Lorgis, M Zeller, G Dentan, P Sicard, P Buffet, I L'Huillier, J C Beer, M Vincent-Martin, H Makki, P Gambert, et al. Prognostic value of N-terminal pro-brain natriuretic peptide in elderly people with acute myocardial infarction: prospective observational study BMJ, May 6, 2009; 338(may06_1): b1605 - b1605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Myerson, S. Coady, H. Taylor, W. D. Rosamond, D. C. Goff Jr, and for the ARIC Investigators Declining Severity of Myocardial Infarction From 1987 to 2002: The Atherosclerosis Risk in Communities (ARIC) Study Circulation, February 3, 2009; 119(4): 503 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. Masoudi, R. O. Bonow, R. G. Brindis, C. P. Cannon, J. DeBuhr, S. Fitzgerald, P. A. Heidenreich, K. K.L. Ho, H. M. Krumholz, C. Leber, et al. ACC/AHA 2008 Statement on Performance Measurement and Reperfusion Therapy: A Report of the ACC/AHA Task Force on Performance Measures (Work Group to Address the Challenges of Performance Measurement and Reperfusion Therapy) J. Am. Coll. Cardiol., December 9, 2008; 52(24): 2100 - 2112. [Full Text] [PDF]
|
|
|
|
|
|
WRITING COMMITTEE MEMBERS, F. A. Masoudi, R. O. Bonow, R. G. Brindis, C. P. Cannon, J. DeBuhr, S. Fitzgerald, P. A. Heidenreich, K. K.L. Ho, H. M. Krumholz, et al. ACC/AHA 2008 Statement on Performance Measurement and Reperfusion Therapy: A Report of the ACC/AHA Task Force on Performance Measures (Work Group to Address the Challenges of Performance Measurement and Reperfusion Therapy) Circulation, December 9, 2008; 118(24): 2649 - 2661. [Full Text] [PDF]
|
|
|
|
 |
|
 P. C. Austin PhD, J. V. Tu MD PhD, D. T. Ko MD MSc, and D. A. Alter MD PhD Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction Can. Med. Assoc. J., October 21, 2008; 179(9): 895 - 900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Covic, P. Gusbeth-Tatomir, and D. Goldsmith Negative outcome studies in end-stage renal disease: how dark are the storm clouds? Nephrol. Dial. Transplant., January 1, 2008; 23(1): 56 - 61. [Full Text] [PDF]
|
|
|
|
|
|
H. M. Krumholz and F. A. Masoudi The Year in Epidemiology, Health Services Research, and Outcomes Research J. Am. Coll. Cardiol., December 4, 2007; 50(23): 2254 - 2262. [Full Text] [PDF]
|
|
|
|
|
|
M. T. Roe, A. Y. Chen, R. H. Mehta, Y. Li, R. G. Brindis, S. C. Smith Jr, J. S. Rumsfeld, W. B. Gibler, E. M. Ohman, and E. D. Peterson Influence of Inpatient Service Specialty on Care Processes and Outcomes for Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Circulation, September 4, 2007; 116(10): 1153 - 1161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. K. Nallamothu, H. M. Krumholz, D. T. Ko, K. A. LaBresh, S. Rathore, M. T. Roe, and L. Schwamm Development of Systems of Care for ST-Elevation Myocardial Infarction Patients: Gaps, Barriers, and Implications Circulation, July 10, 2007; 116(2): e68 - e72. [Full Text] [PDF]
|
|
|
|
 |
|
 P. N. Peterson and F. A. Masoudi Cardiovascular disease and the elderly: can the evidence base avoid irrelevance? Eur. Heart J., June 1, 2007; 28(11): 1277 - 1278. [Full Text] [PDF]
|
|